FSSAI suspends licence of Dior Pharmaceuticals for violations at nutraceutical plant

New Delhi: Food regulator FSSAI has suspended the licence of Dior Pharmaceuticals for multiple violations at its nutraceutical factory.

In a social media post on Thursday, FSSAI observed “serious non-compliances” during the inspection of the manufacturing unit in Punjab.

“The Nutraceutical Manufacturing Unit was found to be operating under severely deficient Good Manufacturing Practices (GMP), Good Hygiene Practices (GHP), and Food Safety Management Systems (FSMS),” the Food Safety and Standards Authority of India (FSSAI) said.

Stating that the deficiencies pose a significant risk to public health, FSSAI said there has been a gross non-compliance with the FSS Act, 2006.

“The FSSAI Licence has been suspended with immediate effect. The FBO (food business operator) has been directed to immediately cease all operations until all deficiencies are rectified and compliance is established to the satisfaction of the Competent Authority,” the regulator said.

Giving details about major and critical non-conformities observed during the inspection, FSSAI said that the regulatory non-compliances were related to infrastructure; sanitation and housekeeping; pest control; storage and handling practices; process controls; personnel hygiene; water quality monitoring; and maintenance of records, among other issues.

The regulator further said that there is a serious failure on the part of the company in ensuring the safety, quality and traceability of food products.

In the last few months, FSSAI has cracked down on many energy drink and alcoholic beverage companies for misleading claims and labelling. It has also issued notices to many e-commerce platforms.

These actions are based on consumer complaints, suo motu cognisance, and regular enforcement activities of food safety officers.

FSSAI posts updates about these enforcement actions against food business operators and e-commerce companies through social media platforms, including Instagram.

“The Nutraceutical Manufacturing Unit was found to be operating under severely deficient Good Manufacturing Practices (GMP), Good Hygiene Practices (GHP), and Food Safety Management Systems (FSMS),” the Food Safety and Standards Authority of India (FSSAI) said.

Stating that the deficiencies pose a significant risk to public health, FSSAI said there has been a gross non-compliance with the FSS Act, 2006.

“The FSSAI Licence has been suspended with immediate effect. The FBO (food business operator) has been directed to immediately cease all operations until all deficiencies are rectified and compliance is established to the satisfaction of the Competent Authority,” the regulator said.

Giving details about major and critical non-conformities observed during the inspection, FSSAI said that the regulatory non-compliances were related to infrastructure; sanitation and housekeeping; pest control; storage and handling practices; process controls; personnel hygiene; water quality monitoring; and maintenance of records, among other issues.

The regulator further said that there is a serious failure on the part of the company in ensuring the safety, quality and traceability of food products.

In the last few months, FSSAI has cracked down on many energy drink and alcoholic beverage companies for misleading claims and labelling. It has also issued notices to many e-commerce platforms.

These actions are based on consumer complaints, suo motu cognisance, and regular enforcement activities of food safety officers.

FSSAI posts updates about these enforcement actions against food business operators and e-commerce companies through social media platforms, including Instagram.

Related Posts

Apollo Navi Mumbai launches geriatric oncology clinic

With a dedicated Geriatric Oncology Clinic, Apollo Hospitals Navi Mumbai brings specialised geriatric cancer care to the private healthcare setting in Navi Mumbai. With the launch of the Geriatric Oncology…

Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

Mumbai: The Food and Drug Administration (FDA) has cracked down on medical stores violating drug-sale rules, suspending 599 licences and cancelling another 141 after inspecting 2,295 retail establishments across the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Apollo Navi Mumbai launches geriatric oncology clinic

Apollo Navi Mumbai launches geriatric oncology clinic

Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

Baddi pharma firm loses licence after 1,200-kg tapentadol haul

Baddi pharma firm loses licence after 1,200-kg tapentadol haul

US FDA takes steps to maintain newborn access to life-saving starter nutrition products

US FDA takes steps to maintain newborn access to life-saving starter nutrition products

Mankind Pharma launches campaign to inspire 1 crore Indians to pledge for organ donation